Video

Know Your Own Strengths And Weaknesses Before Selecting A CDMO

Source: Outsourced Pharma

In this segment of the Outsourced Pharma Live virtual event A New Age For Small Molecule Development, Sesha Neervannan, PhD, COO, Tarsus Pharmaceuticals and Bethany Dudek, Chief Technology Officer, Arcutis, share thoughts about selecting small, boutique service providers versus large, full service CDMOs, as well as key attributes they look for in a potential partner. Dudek also talks about why it’s important to know your own internal strengths and weaknesses before selecting a CDMO.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)